Maximize Returns on Inhibrx Inc. (INBX) Investments Using Our Online Dividend Calculator.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Barings Participation Investors
Credit Suisse High Yield Bond Fund
Alpine Income Property Trust Inc.
Blackstone Long Short Credit Income Fund
OFS Credit Company Inc.
Alico Inc.
BlackRock Income Trust Inc. (The)
Allspring Global Dividend Opportunity Fund of Beneficial Interest